• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤免疫逃逸:机制与活性靶点

Tumor escape from immune response: mechanisms and targets of activity.

作者信息

Gabrilovich Dmitry, Pisarev Vladimir

机构信息

H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33612, USA.

出版信息

Curr Drug Targets. 2003 Oct;4(7):525-36. doi: 10.2174/1389450033490849.

DOI:10.2174/1389450033490849
PMID:14535653
Abstract

Immune system plays an important role in control of tumor progression. Effective antitumor immune response depends on close interaction of several elements of immune system. They include antigen-presenting cells, different subsets of T cells, B cells and NK cells. However, tumor cells developed a number of mechanisms to escape recognition and elimination by immune system. In this review we will discuss these mechanisms and address possible approaches to correct them.

摘要

免疫系统在控制肿瘤进展中发挥着重要作用。有效的抗肿瘤免疫反应依赖于免疫系统多个要素的密切相互作用。这些要素包括抗原呈递细胞、不同亚群的T细胞、B细胞和自然杀伤细胞。然而,肿瘤细胞形成了多种机制来逃避被免疫系统识别和清除。在本综述中,我们将讨论这些机制,并探讨纠正它们的可能方法。

相似文献

1
Tumor escape from immune response: mechanisms and targets of activity.肿瘤免疫逃逸:机制与活性靶点
Curr Drug Targets. 2003 Oct;4(7):525-36. doi: 10.2174/1389450033490849.
2
Role of immature myeloid cells in mechanisms of immune evasion in cancer.未成熟髓样细胞在癌症免疫逃逸机制中的作用
Cancer Immunol Immunother. 2006 Mar;55(3):237-45. doi: 10.1007/s00262-005-0048-z. Epub 2005 Jul 27.
3
[Cancer immunotherapy. Importance of overcoming immune suppression].[癌症免疫疗法。克服免疫抑制的重要性]
Medicina (B Aires). 2010;70(6):565-70.
4
[Immune system and tumors].[免疫系统与肿瘤]
Ann Pathol. 2017 Feb;37(1):11-17. doi: 10.1016/j.annpat.2016.12.004. Epub 2017 Jan 31.
5
MHC class I antigens and immune surveillance in transformed cells.I类主要组织相容性复合体抗原与转化细胞中的免疫监视
Int Rev Cytol. 2007;256:139-89. doi: 10.1016/S0074-7696(07)56005-5.
6
Natural killer cell immune escape in acute myeloid leukemia.自然杀伤细胞免疫逃逸在急性髓系白血病中的作用。
Leukemia. 2012 Sep;26(9):2019-26. doi: 10.1038/leu.2012.87. Epub 2012 Mar 26.
7
Tumor escape from immune surveillance.肿瘤逃避免疫监视。
Arch Immunol Ther Exp (Warsz). 1999;47(2):83-8.
8
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?将肿瘤细胞转化为抗原呈递细胞:改善癌症免疫疗法的下一步?
Eur J Cancer. 2016 Nov;68:134-147. doi: 10.1016/j.ejca.2016.09.010. Epub 2016 Oct 15.
9
NK cells to cure cancer.自然杀伤细胞治疗癌症。
Semin Immunol. 2019 Feb;41:101272. doi: 10.1016/j.smim.2019.03.004. Epub 2019 May 10.
10
Immunosuppressive strategies that are mediated by tumor cells.由肿瘤细胞介导的免疫抑制策略。
Annu Rev Immunol. 2007;25:267-96. doi: 10.1146/annurev.immunol.25.022106.141609.

引用本文的文献

1
Biomaterials Facilitating Dendritic Cell-Mediated Cancer Immunotherapy.生物材料促进树突状细胞介导的癌症免疫治疗。
Adv Sci (Weinh). 2023 Jun;10(18):e2301339. doi: 10.1002/advs.202301339. Epub 2023 Apr 23.
2
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-Mediated Tumor Immunotherapy.内源性/外源性纳米疫苗协同增强树突状细胞介导的肿瘤免疫治疗。
Adv Healthc Mater. 2023 Jul;12(17):e2203028. doi: 10.1002/adhm.202203028. Epub 2023 Mar 1.
3
Anti-Tumor Effect of Parasitic Protozoans.寄生原生动物的抗肿瘤作用
Bioengineering (Basel). 2022 Aug 16;9(8):395. doi: 10.3390/bioengineering9080395.
4
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma.针对谁的 T 细胞在肆虐?双特异性 T 细胞接合器在神经胶质瘤中的作用。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003679.
5
An 11-gene signature for the prediction of systemic recurrences in colon adenocarcinoma.用于预测结肠腺癌全身复发的11基因特征。
Gastroenterol Rep (Oxf). 2021 Aug 25;9(5):451-460. doi: 10.1093/gastro/goab023. eCollection 2021 Oct.
6
The role of Human leukocyte antigen class I on patient survival in Gastrointestinal cancers: a systematic review and meta- analysis.人类白细胞抗原 I 类在胃肠道癌患者生存中的作用:系统评价和荟萃分析。
Sci Rep. 2020 Jan 20;10(1):728. doi: 10.1038/s41598-020-57582-x.
7
Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.术前中性粒细胞与淋巴细胞比值对胃癌根治性切除联合CIK辅助免疫治疗及术后化疗后生存率的预测价值
J Cancer Res Clin Oncol. 2017 May;143(5):861-871. doi: 10.1007/s00432-016-2330-1. Epub 2017 Jan 20.
8
Clinical implications of human leukocyte antigen class I expression in endometrial cancer.人类白细胞抗原I类分子在子宫内膜癌中的表达的临床意义
Mol Clin Oncol. 2015 Nov;3(6):1285-1290. doi: 10.3892/mco.2015.636. Epub 2015 Sep 3.
9
Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.白细胞介素-1及1型和2型白细胞介素-1受体在霍奇金淋巴瘤中的表达
PLoS One. 2015 Sep 25;10(9):e0138747. doi: 10.1371/journal.pone.0138747. eCollection 2015.
10
Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity.靶向光动力疗法诱导的抗癌免疫中的表观遗传过程。
Front Oncol. 2015 Jul 30;5:176. doi: 10.3389/fonc.2015.00176. eCollection 2015.